Expression of COX-2 protein in colorectal carcinoma and the clinical implication

Abstract

Abstract: Objective To investigate the relationship between COX-2 expression and the clinicopathological factors in colorectal carcinoma and assess the prognostic value of COX-2 detection. Methods Tissue microarray and immunohistochemistry by SABC method was employed for detecting COX-2 expression in 126 patients with advanced colorectal cancer, and the relationship of COX-2 expression with the clinicopathological features and prognosis of the patients was retrospectively analyzed. Results The patients were divided into two groups of low and high COX-2 groups according to the grade and extent of COX-2 expression. High COX-2 expression was detected in 32 (25.4%) cases, and low expression in 94 (74.6%) cases. No significant correlation was noted between COX-2 expression and the patients’ age, sex, tumor size, tumor location, histological type, lymphatic-node metastasis and Dukes’ classification, but high COX-2 expression was strongly correlated with tumor recurrence and especially with blood-borne metastasis (P<0.05). The survival rate without tumor recurrence for high-and low-COX-2 groups was assessed by the Kaplan-Meier method and compared by log-rank test, which revealed significant difference between the two groups (P=0.0067). Multivariate analysis for all patients suggested that among the 8 prognostic factors (age, sex, tumor size, tumor location, histological type, lymphatic-node metastasis, Dukes’ stage, and COX-2 expression), Dukes’ stage and COX-2 expression was the independent significant factor related to disease-free survival. Conclusion The expression of COX-2 is strongly correlated with recurrence of colorectal cancer, especially with blood-borne metastasis. COX-2 is an independent factor for prognostic evaluation of the patients, and tissue microarray allows rapid, convenient, economic and accurate COX-2 detection for large-scale application.

CLC Number:

Q78
R735.3

YAO Hong-bing¹, WU Ai-guo², CHEN You-jiang¹, TANG Bin-hua¹. Expression of COX-2 protein in colorectal carcinoma and the clinical implication[J]. Journal of Southern Medical University, 2005, 25(12): 1524-1528.

References

[1] 曹歌,沈志祥.前列腺素与结直肠肿瘤[J].世界华人消化杂志,2001,9(4):431-4.Cao G,Shen ZX.Prostaglandin and the carcinoma of colorectal[J].World J Gastroenterol,2001,9(4):431-4.
[2] Kosaka T,Miyata A,Ihara H,et al.Characterization of the hman gene (PTGS2) encoding prostaglandin-endoperoxide synthase [J].Eur J Biochem,1994,221(3):889-97.
[3] Morita I,Schindler M,Regier MK,et al.Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2 [J].J Biol Chem,1995,270(8):10902-8.
[4] Kinoshita T,Takahashi Y,Sakashita T,et al.Growth stimulation and induction of epidermal growth factor receptor by overex pression of cyclooxygenases 1 and 2 in human colon carcinoma cells [J].Biochim Biophys Acta 1999,1438(1):120-30.
[5] Hla T,Neilson K.Human cyclooxygenase-2 cDNA [J].Proc Natl Acad Sci USA,1992,89(16):7384-8.
[6] Tomozawa S,Nagawa H,Tsuno N,et al.Inhibition ofhaematogenous metastasis of colon cancer in mice by a selective COX-2inhibitor,JTE-522[J].Br J Cancer,1999,81(8):1274-79.
[7] Lynch PM.COX-2 inhibition in clinical cancer prevention [J].Oncology (Huntingt),2001,15(3 Supple 5):21-6.
[8] Gupta RA,Dubois RN.Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 [J].Nat Rev Cancer,2001,1(1):11-21.
[9] Murata H,Kawano S,Tsuji S,et al.Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma[J].Am J Gastroenterol,1999,94(2):451-5.
[10] Li G,Yang T,Yan J.Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells [J].Biochem Biophys Res Commun,2002,299(5):886-90.
[11] Sun B,Wu YL,Zhang XJ,et al.Effects of Sulindac on growth inhibition and apoptosis induction in human gastric cancer cells [J].World J Gastroenterol,2001,9(9):997-1002
[12] Wu YL,Sun B,Zhang XJ,et al.Grow th inhibition and apoptosis induction of Sulindac on Human gastric cancer cells [J].World J Gastroenterol,2001,7(7):796-800.
[13] Tsujii M,Kawano S,Tsuji S,et al.Cyclooxygenase regulates angiogenesis induced by colon cancer cells[J].Cell 1998,93(5):705-16.
[14] Cianchi F,Cortesini C,Bechi P,et al.Up-regulation of cyclooxygenase-2 gene expression correlates with tumor angiogenesis in human colorectal cancer [J].Gastroenterology,2001,121 (6):1339-47.
[15] Daniel TO,Liu H,Morrow JD,et al.Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis[J].Cancer Res,1999,59(18):4574-7.
[16] Tian G,Yu JP,Luo HS,et al.Effect ofNimesulid e on proliferation and apoptosis of human hepatoma SMMC-7721 cells [J].World J Gastroenterol,2002,8(3):483-7.
[17] Zhang JZ,Huang YW,Liu DM,et al.Tissue microarray technology and its preliminary application in large intestinal carcinoma [J].World J Gastroenterol,2002,10(2):157-60.
[18] Wu QM,Li SB,Wang Q,et al.The expression of COX-2 in esophageal carcinoma and its relation to clinicopathologic characteristic [J].World J Gastroenterol,2001,9(1):11-4.
[19] Shen ZX,Cao G,Sun J.The clinical and pathology effect of COX-2mRNA expression in colorectal cancers [J].World J Gastroenterol,2001,9(9):1082-4.
[20] Wolff H,Saukkonen K,Anttila S,et al.Expression of cyclooxygenase-2 in human lung carcinoma [J].Cancer Res 1998,58(22):4997-5001.
[21] Shiota G,Okubo M,Noumi T,et al.Cyclooxygenase-2 expression in hepatocellular carcinoma [J].Hepatogastroenterology,1999,46(25):407-12
[22] Chen WS,Wei SJ,Liu JM,et al.Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2expression and inhibited by a COX-2-selective inhibitor,etodolac [J].Int J Cancer,2001,91(6):894-9.
[23] Liu XH,Kirschenbuam A,Yao S,et al.Up-regulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell lines [J].Clin Exp Metastasis 1999,17(8):687-94.
[24] Cianchi F,Cortesini C,Bechi P,et al.Up-regulation of cyclooxygenase 2 gene expression correlates with rumor angiogenesis in human colorectal cancer [J].Gastroenterology 2001,121(6):1339-47.
[25] Tsujii M,Kawano S,Dubois RN.Cyclooxygenase-2 expression in human colon cancer cells increase metastatic potential [J].Proc Natl Acad Sci USA,1997,94(7):3336-3340.
[26] Yamamoto S,Konishi I,Mandai M,et al.Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasm:correlation with chinicopathology and patient survival,and analysis of serum VEGF[J].Br J Cancer,1997,76(9):1221-7.
[27] Murata H,Kawano S,Tsuji S,et al.Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma[J].Am J Gastroenterol,1999,94:451-5.
[28] Li G,Yang T,Yan J.Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells [J].Biochem Biophys Res Commun,2002,299(5):886-90.
[29] Yamauchi T,Watanabe M,Kubota T,et al.Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer [J].Dis Colon Rectum,2002,45(1 ):98-103.
[30] Hull MA,Fenwick SW,Chapple KS,et al.Cyclooxygenase-2expression in colorectal cancer liver metastases [J].Clin Exp Metastasis,2000,18(1):21-7.

Related Articles 15

[1]	ZHANG Lei1,2,CHEN Jian-ping1,2,ZHANG Li1,2,WANG Tao1,LIU Ming-jie1,TIAN Yu1 Department of Parasiotology1,Key Laboratory of Chronobiology of Ministry of Health2,West China Medical Center,Sichuan University,Chengdu 610041,China. Construction of a prokaryotic expression vector carrying mompS-linker-flaA fusion gene and its expression in E.coli [J]. Journal of Southern Medical University, 2006, 26(12): 1701-1705.
[2]	WANG Quan-shi1,WANG Xin-lu2,LI Hua3,WANG Qiao-yu1,WANG Quan-ying4,YANG Guang-xiao4 1PET Center,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China;2PET Center of Department of Nuclear Medicine,Guangzhou General Hospital of Guangzhou Command,Guangzhou 510010,China;3Third Affiliated Hospital of Sun Yat-sen University,Guangzhou 510630,China;4Xi’an Huaguang Bioengineering Company,Xi’an 710025,China. Construction of a retroviral vector for RNA interference targeting human telomerase reverse transcriptase [J]. Journal of Southern Medical University, 2006, 26(12): 1715-1719.
[3]	LI De-liang,MA Wen-li,SHI Yong-xia,LI Ling,ZHANG Bao,ZHENG Wen-ling Institute of Genetic Engineering,Southern Medical University,Guangzhou 510515,China. Construction of a eukaryotic expression plasmid containing gp120 gene of HIV-1 subtype B and its expression in HepG2 cells [J]. Journal of Southern Medical University, 2006, 26(12): 1724-1727.
[4]	YUAN Ai-qin,HE Yuan-li,YANG Fang,LIU Mu-biao Department of Obstetrics and Gynecology,Zhujiang Hospital,Southern Medical University,Guangzhou 510282,China. Construction of a recombinant adenoviral vector expressing human endostatin [J]. Journal of Southern Medical University, 2006, 26(12): 1769-1771.
[5]	JIANG Hong-chao1,2,SUN Qiang-ming1,ZHAO Dan2,SUN Mao-sheng1,LU Lin2,LI Hong-jun1 1Department of Molecular Biology,Institute of Medical Biology,Chinese Academy of Medical Sciences and Peking Union Medical College,Kunming 650118,China;2Graduate School of Kunming Medical College,Kunming 650031,China. RNA interference-mediated inhibition of survivin expression in Hela cell line by siRNA expression vector targeting survivin gene [J]. Journal of Southern Medical University, 2006, 26(12): 1806-1811.
[6]	SHAO Zi-yun,LIU Zhi-feng,PENG Yi,XU Jia,DENG Peng,JIANG YongKey Laboratory of Functional Proteomics of Guangdong Province,Southern Medical University,Guangzhou 510515,Chin. Construction of a recombinant adenovirus vector for interferon-γ-inducible protein 10 and the adenovirus preparation [J]. Journal of Southern Medical University, 2006, 26(11): 1552-1555.
[7]	MA Shu-dong1,LUO Rong-cheng1,DING Zheng-hua2,YUAN Chang-qing2,DING Xue-mei1 Department of Oncology,Nanfang Hospital1,Department of Radiation Medicine,Institute of Tropical Medicine2,Southern Medical University,Guangzhou 501515,Chin. Construction and identification of recombinant adenoviruses containing the gene fragments encoding Her2/neu extracellular and transmembrane domains [J]. Journal of Southern Medical University, 2006, 26(11): 1641-.
[8]	LI Hai-yu, GUO Ai-hua, LIU Zhi-feng, LIU Yu, LIU Jing-hua, DENG Peng, LI Zhi-jie, LIU Ya-wei, JIANG Yong Department of Pathophysiology and Key Laboratory of Functional Proteomics of Guangdong Province, Southern Medical University, Guangzhou 510515, China. Construction and functional study of a cell penetrating peptide-based expression vector for targeted delivery of proteins into the cell nuclei [J]. Journal of Southern Medical University, 2006, 26(10): 1394-.
[9]	YANG Pei1, WANG Kun-zheng1, SHI Zhi-bin1, DANG Xiao-qian1, YU Peng-bo2, WANG Chun-sheng1, GONG Fu-liang3 1Department of Orthopedics, Second Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, Xi’an 710004, China; 2Institute of Virus Research, Center for Disease Control and Prevention of Shaanxi Province, Xi’an 710054, China; 3Department of Orthopedics, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China. Prokaryotic expression, purification and activity assay of recombinant vascular endothelial growth factor [J]. Journal of Southern Medical University, 2006, 26(09): 1263-1268.
[10]	XING Rui, YANG Xiao-qiang, CHEN Xue-qing, ZHANG Zhen-shu Institute for Digestive Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. Construction of Lactococcus lactis expression vector of recombinant human trefoil factor family 2 [J]. Journal of Southern Medical University, 2006, 26(09): 1280-1283.
[11]	REN Shu-ting1, YU Lin-hua1, XU Chang-fu1, GAO Guang-dao2 Department of Pathology1, Department of Physiology and Pathophysiology2, Medical College of Xi’an Jiaotong University, Xi’an 710061, China. Construction and identification of tetracycline-inducible rat Smad7 eukaryotic expression vector [J]. Journal of Southern Medical University, 2006, 26(09): 1313-1315.
[12]	DONG Xiao1,2, WANG Jia-ning1, HUANG Yong-zhang1, GUO Ling-yun1 1Institute of Clinical Medicine, People’s Hospital of Yunyang Medical College, Shiyan 442000, China; 2School of Medicine, Wuhan University, Wuhan 430060, China. Expression and purification of PEP-1-EGFP fusion protein and its transduction into human umbilical vein endothelial cells [J]. Journal of Southern Medical University, 2006, 26(08): 1114-1117.
[13]	LIU Ming-Jie1, CHEN Jian-ping1, WANG Tao1, LIAO Tao2, CHEN Xian1, LU Dian-xiang3, TIAN Yu1 1Department of Parasitology, West China Medical Center, Sichuan University, Chengdu 610041, China; 2Department of Diagnostics, North Sichuan Medical College, Luzhou 637000, China; 3Biomaterial Engineering Research Center, Sichuan University, Chengdu 610064, China. Legionella pneumophila lvgA and Hsp60 gene splicing and the fusion gene expression in E. coli [J]. Journal of Southern Medical University, 2006, 26(07): 904-909.
[14]	LI Yan, BAO Lang, ZHANG Hui-dong, LI Ya-sha, ZHU Hai-long Laboratory of Infection and Immunity, College of Preclinical and Forensic Medicine, West China Medical Center of Sichuan University, Chengdu 610041, China. Construction of recombinant Mycobacterium smegmatis expressing ESAT-6 and its effects on macrophages [J]. Journal of Southern Medical University, 2006, 26(07): 923-926.
[15]	ZOU Hong-Yun1, MA Li1, YAO Xin-sheng1, WEN Qian1, LUO Wei1, WANG Xiao-Ning2 1Institute of Molecular Immunology, School of Biotechnology, Southern Medical University, Guangzhou 510515, China; 2School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510641, China. Effects of T cell receptor gene rearrangement on BV CDR3 in Jurkat cells [J]. Journal of Southern Medical University, 2006, 26(07): 939-943.